Dieuwke Strijker

Ms. Dieuwke Strijker

Surgery, Radboud university medical center, Nijmegen, The Netherlands
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2022 in Cancers
Verified
Journal Article
Open access
PDF file
JDJoelle Dhanis
Joelle Dhanis
NKNathaniel Keidan
Nathaniel Keidan
DBDominic Blake
Dominic Blake
Stuart RundleStuart Rundle
Stuart Rundle
DSDieuwke Strijker
Dieuwke Strijker
ASAnke Smits
Anke Smits
The literature evaluating the effect of prehabilitation programmes on postoperative outcomes and quality of life of patients with gynaecological cancer undergoing surgery was reviewed. Databases including Pubmed, Medline, EMBASE (Ovid) and PsycINFO were systematically searched to identify studies evaluating the effect of prehabilitation programmes on patients with gynaecological cancer. Both unimodal and multimodal prehabilitation programmes were included encompassing physical exercise and nutritional and psychological support. Primary outcomes were surgical complications and quality of life. Secondary outcomes were anthropometric changes and adherence to the prehabilitation programme. Seven studies fulfilled the inclusion criteria, comprising 580 patients. Included studies were nonrandomised prospective studies (n = 4), retrospective studies (n = 2) and one case report. Unimodal programmes and multimodal programmes were included. In patients with ovarian cancer, multimodal prehabilitation resulted in significantly reduced hospital stay and time to chemotherapy. In patients with endometrial and cervical cancer, prehabilitation was associated with significant weight loss, but had no significant effects on surgical complications or mortality. No adverse events of the programmes were reported. Evidence on the effect of prehabilitation for patients with gynaecological cancer is limited. Future studies are needed to determine the effects on postoperative complications and quality of life.

28 April 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
SESabien Hannah van Exter
Sabien Hannah van Exter
LDLuuk Drager
Luuk Drager
MAMonique J. M. D. van Asseldonk
Monique J. M. D. van Asseldonk
DSDieuwke Strijker
Dieuwke Strijker
NSNina D. van der Schoot
Nina D. van der Schoot
MBManon G. A. van Den Berg
Manon G. A. van Den Berg
Multimodal prehabilitation programs to improve physical fitness before surgery often include nutritional interventions. This study evaluates the efficacy of and adherence to a nutritional intervention among colorectal and esophageal cancer patients undergoing the multimodal Fit4Surgery prehabilitation program. The intervention aims to achieve an intake of ≥1.5 g of protein/kg body weight (BW) per day through dietary advice and daily nutritional supplementation (30 g whey protein). This study shows 56.3% of patients met this goal after prehabilitation. Mean daily protein intake significantly increased from 1.20 ± 0.39 g/kg BW at baseline to 1.61 ± 0.41 g/kg BW after prehabilitation (p < 0.001), with the main increase during the evening snack. BW, BMI, 5-CST, and protein intake at baseline were associated with adherence to the nutritional intervention. These outcomes suggest that dietary counseling and protein supplementation can significantly improve protein intake in different patient groups undergoing a multimodal prehabilitation program.

1 March 2022 in European Journal of Surgical Oncology
Verified
Journal Article
Open access
DSDieuwke Strijker
Dieuwke Strijker
WMW.J.H.J. Meijerink
W.J.H.J. Meijerink
ABA.J.A. Bremers
A.J.A. Bremers
PRP. de Reuver
P. de Reuver
CLC.J.H.M. van Laarhoven
C.J.H.M. van Laarhoven
BHB. van Den Heuvel
B. van Den Heuvel
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) leads to increased survival rates in patients with peritoneal carcinomatosis, but is associated with considerable morbidity and mortality rates. Prehabilitation, a process to optimize a patient's preoperative functional capacity, has a positive impact on recovery after colorectal surgery. The impact of prehabilitation in patients undergoing HIPEC is scarcely investigated. This scoping review and narrative synthesis aims to summarize and evaluate what is currently reported about the effect of prehabilitation on postoperative outcomes after HIPEC. A literature search of studies reporting on the effect of prehabilitation on outcomes after HIPEC was performed (August 2020). Study characteristics, patient demographics, composition of prehabilitation programs, and reported outcomes used to quantify the effect of prehabilitation were recorded. The literature search did not yield any studies on the effect of prehabilitation programs on outcomes after HIPEC. As an alternative, studies identifying modifiable risk factors for poor postoperative outcomes after HIPEC that can be targeted by prehabilitation were reviewed to evaluate starting points for prehabilitation. Fourteen studies identify the following preoperative factors: poor nutritional status, poor performance status, low health related quality of life and an history of smoking. No research has been published on the effect of prehabilitation prior to HIPEC. This review demonstrates that preoperative modifiable risk factors for outcomes in patients undergoing HIPEC are multifactorial. A multimodal prehabilitation program prior to HIPEC, including nutritional support, psychical exercise, psychological support and smoking cessation, might therefore be a promising approach to improve postoperative outcomes.

20 March 2023 in Cancers
Verified
Journal Article
Open access
PDF file
DSDieuwke Strijker
Dieuwke Strijker
WMWilhelmus J. H. J. Meijerink
Wilhelmus J. H. J. Meijerink
LHLinda A. G. van Heusden-Schotalbers
Linda A. G. van Heusden-Schotalbers
MBManon G. A. van Den Berg
Manon G. A. van Den Berg
MAMonique J. M. D. van Asseldonk
Monique J. M. D. van Asseldonk
BHBaukje van Den Heuvel
Baukje van Den Heuvel
Background: Surgery for complex primary and metastatic colorectal cancer (CRC), such as liver resection and hyperthermic intraperitoneal chemotherapy (HIPEC), in academic settings has led to improved survival but is associated with complications up to 75%. Prehabilitation has been shown to prevent complications in non-academic hospitals. This pilot study aimed to determine the feasibility and potential efficacy of a multimodal prehabilitation program in patients undergoing surgery in an academic hospital for complex primary and metastatic CRC. Methods: All patients awaiting complex colorectal surgery, liver resection, or HIPEC from July 2019 until January 2020 were considered potentially eligible. Feasibility was measured by accrual rate, completion rate, adherence to the program, satisfaction, and safety. To determine potential efficacy, postoperative outcomes were compared with a historical control group. Results: Sixteen out of twenty-five eligible patients (64%) commenced prehabilitation, and fourteen patients fully completed the intervention (88%). The adherence rate was 69%, as 11 patients completed >80% of prescribed supervised trainings. No adverse events occurred, and all patients expressed satisfaction with the program. The complication rate was significantly lower in the prehabilitation group (37.5%) than the control group (70.2%, p = 0.020). There was no difference in the type of complications. Conclusion: This pilot study illustrates that multimodal prehabilitation is feasible in the majority of patients undergoing complex colorectal cancer, liver resection, and HIPEC in an academic setting.

29 February 2024 in Cancers
Verified
Journal Article
Open access
PDF file
JDJoelle Dhanis
Joelle Dhanis
DSDieuwke Strijker
Dieuwke Strijker
LDLuuk Drager
Luuk Drager
MHMaaike Van Ham
Maaike Van Ham
KLKees van Laarhoven
Kees van Laarhoven
BHBaukje van Den Heuvel
Baukje van Den Heuvel
Prehabilitation is an upcoming strategy to optimize patient’s functional capacity, nutritional status, and psychosocial well-being in order to reduce surgical complications and enhance recovery. This study aims to assess the feasibility of implementing a multimodal prehabilitation program into the standard care of gynecological oncology patients at an academic hospital in terms of recruitment, adherence, and safety, which were assessed by the number of patients eligible, recruitment rate, participation rate, and adherence to individual modalities. Data were derived from the F4S PREHAB trial, a single-center stepped-wedge trial implementing a multimodal prehabilitation program among various surgical specialties. All patients undergoing elective surgery as part of treatment for ovarian, uterine, and vulvar cancer at the Radboudumc, an academic hospital in The Netherlands, between May 2022 and September 2023 were considered eligible for the F4S PREHAB trial and, consequently, were included in this cohort study. The multimodal prehabilitation program comprised a physical exercise intervention, nutritional intervention, psychological intervention, and an intoxication cessation program. A total of 152 patients were eligible and approached for participation of which 111 consented to participate, resulting in a recruitment rate of 73%. Participants attended an average of six exercise sessions and adhered to 85% of possible training sessions. Respectively, 93% and 98% of participants adhered to the prescribed daily protein and vitamin suppletion. Ten participants were referred to a psychologist and completed consultations. Out of nine active smokers, two managed to quit smoking. A total of 59% adhered to alcohol cessation advice. No adverse events were reported. This study demonstrates that introducing a multimodal prehabilitation program into the standard care of gynecological oncology patients is feasible in terms of recruitment and adherence, with no serious adverse events.

6 November 2023 in British Journal of Surgery
Verified
Journal Article
Open access
PDF file
DSDieuwke Strijker
Dieuwke Strijker
THThomas J Hoogeboom
Thomas J Hoogeboom
JMJeroen W J H Meijerink
Jeroen W J H Meijerink
ATAnn Taveirne
Ann Taveirne
WSWilhelmina H Schreurs
Wilhelmina H Schreurs
BHBaukje van Den Heuvel
Baukje van Den Heuvel
Colonic carcinoma (CC) is a highly prevalent cancer in the Netherlands, with almost 9000 new cases annually1. Adjuvant chemotherapy is recommended for patients with lymph node metastases (stage 3 disease) to improve survival2. A significant proportion of patients with stage 3 CC do not start chemotherapy in time or require treatment adaptions owing to toxicity3,4, with worrisome decreased survival rates as a result.